Chemical Compound

Cgamp

CAS Registry Number 849214-04-6
Back to search Request a Quote
Cgamp chemical structure
Primary Record

Cgamp

In stock
3,186 g
Purity
98.9 %
CAS
849214-04-6

Compound Identifiers & Properties

CAS
849214-04-6
PubChem CID
135471108
SMILES
C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)OP(=O)(OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)O)OP(=O)(O1)O)O
Canonical SMILES
Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]4[C@@H](O)[C@H](n5cnc6c(N)ncnc65)O[C@@H]4COP(=O)(O)O[C@H]3[C@H]2O)c(=O)[nH]1

Names & Synonyms

  • Cgamp
  • cyclic GMP-AMP
  • c-GpAp
  • c-GMP-AMP
  • Cyclic AMP-GMP
  • cGamp disodium salt
  • c-GpAp sodium salt
  • 849214-04-6
  • cGAMP; c-GpAp
  • 3',5'-cyclic GMP-AMP
  • cAMP-GMP
  • RefChem:331508
  • 3',3'-Cyclic GAMP
  • 3',3'-cGAMP
  • CHEMBL4449584
  • CHEBI:71580
  • orb548674
  • orb1708019
  • orb1733731
  • 3'3'-cGAMP (sodium salt)?
  • SCHEMBL19940046
  • DTXSID401045334
  • 3 ,3 -cGAMP
  • EX-A2911
  • C20H24N10O13P2
  • BDBM50509401
  • ZINC95626233
  • AKOS030526925
  • c[G(3',5')pA(3',5')p]
  • CS-3892
  • CID11181459
  • CID 11169859
  • Cyclic [G(3',5')pA(3',5')p]
  • DA-62234
  • HY-12512
  • NC137624
  • c(G(3',5')pA(3',5')p)
  • J2.297.549H
  • C76713
  • 3'3'-Cyclic guanosine monophosphate-adenosine monophosphate
  • Q27139728
  • 2-Amino-9-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecin-2-yl)-3,9-dihydro-6H-purin-6-one
  • 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
  • 2-amino-9-[(2R,3R,3aS,7aR,9R,10R,10aS,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-yl]-1,9-dihydro-6H-purin-6-one
  • 3',3' cGAMP; c-GMP-AMP; c[G(3',5')pA(3',5')p]
  • 3',3'-Cyclic guanosine monophosphate-adenosine monophosphate
  • 3'-Guanylic acid, adenylyl-(3'-->5')-, cyclic nucleotide
  • 2-Amino-9-[(2r,3r,3as,5r,7ar,9r,10r,10as,12r,14ar)-9-(6-Amino-9h-Purin-9-Yl)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecin-2-Yl]-1,9-Dihydro-6h-Purin-6-One
  • 3 -O,5 -O-[(Adenosine-3 -O,5 -O-diyl)bisphosphinico]guanosine
  • 3 -O,5 -O-[(Guanosine-3 -O,5 -O-diyl)bisphosphinico]adenosine
  • 3 -O,5 -O-[(Guanosine-5 -O,3 -O-diyl)bisphosphinico]adenosine
  • 3''-Guanylic acid, adenylyl-(3'' inverted exclamation marku5'')-, cyclic nucleotide
  • 3'-Guanylic acid, adenylyl-(3' inverted exclamation marku5')-, cyclic nucleotide
  • Adenosine 3 ,5 -bisphosphoric acid 3 ,5 -dideoxyguanosine 5 ,3 -diyl ester
  • Adenosine-3 ,5 -bisphosphoric acid 3 ,5 -dideoxyguanosine-5 ,3 -diyl ester
  • (1S,6R,8R,9R,10S,15R,17R,18R)-8-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-17-(6-amino-9H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-3,12-dione
  • 1-(6-Amino-9H-purine-9-yl)-1 -(2-amino-6-oxo-1,6-dihydro-9H-purine-9-yl)[3-O,5 -O-(hydroxyphosphinylidene)-5-O,3 -O-(hydroxyphosphinylidene)bis(1-deoxy-beta-D-ribofuranose)]
  • 2-amino-9-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-9-(6-amino-9H-purin-9-yl)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro(3,2-d:3',2'-j)(1,3,7,9,2,8)tetraoxadiphosphacyclododecin-2-yl)-1,9-dihydro-6H-purin-6-one
  • 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3|E5,12|E5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
  • 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-3H-purin-6-one
  • 4BW